Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Immune Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02046616
What this trial is testing

Subcutaneous (SC) Tocilizumab (RoActemra/Actemra) in Participants With Active Rheumatoid Arthritis (RA) and Inadequate Response to Disease-Modifying Anti-Rheumatic Drugs (DMARDs)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 133
Not applicableStudy completedNCT01531855
What this trial is testing

Post-exercise Insulin Reductions in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Northumbria University 13
Not applicableUnknownNCT01617590
What this trial is testing

Disease-Modifying Antirheumatic Drugs Cycle Combination Therapy Research

Who this might be right for
Rheumatoid Arthritis
Shanxi Medical University 500
Post-approval studies (Phase 4)Ended earlyNCT01661140
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Severe Active Rheumatoid Arthritis, Comparing Tapering Versus Maintaining the Methotrexate Dosage

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 427
Early research (Phase 1)UnknownNCT01232660
What this trial is testing

Hydroxychloroquine for Discordant CD4 Responders on Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infection
St Stephens Aids Trust 12
Not applicableStudy completedNCT00001110
What this trial is testing

Effect of Anti-HIV Therapy (HAART) on HIV Levels in the Lungs and on Lung Cell Inflammation in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Testing effectiveness (Phase 2)Study completedNCT06099535
What this trial is testing

LNK01001 Capsule in Moderately to Severely Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Lynk Pharmaceuticals Co., Ltd 156
Large-scale testing (Phase 3)Study completedNCT02006706
What this trial is testing

MabThera/Rituxan (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis and Inadequate Response to DMARD Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 15
Large-scale testing (Phase 3)Study completedNCT01350804
What this trial is testing

Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents (CAIN457F2309 and CAIN457F2309E1)

Who this might be right for
Rheumatoid Arthritis
Novartis Pharmaceuticals 551
Large-scale testing (Phase 3)Study completedNCT00791999
What this trial is testing

Efficacy Confirmation Trial of CDP870 as add-on Medication to Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Otsuka Pharmaceutical Co., Ltd. 316
Testing effectiveness (Phase 2)Study completedNCT01211249
What this trial is testing

GLPG0259 in Methotrexate-refractory Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Lakefront Biotherapeutics NV 30
Not applicableEnded earlyNCT04084223
What this trial is testing

JAKPOT (JAK Inhibitors and Predictors of Outcome in RheumaToid Arthritis)

Who this might be right for
Rheumatoid Arthritis
University Hospital, Montpellier 51
Large-scale testing (Phase 3)Ended earlyNCT00673920
What this trial is testing

Evaluate Ocrelizumab Compared With Placebo in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Therapy

Who this might be right for
Rheumatoid Arthritis
Genentech, Inc. 314
Not applicableNot Yet RecruitingNCT06846645
What this trial is testing

Host Response to Infection by Direct Analysis of Leukocyte Single Cell-type Gene Expression/transcript Abundance, Direct LS-TA. a Prospective Study Will Evaluate the Performance of Direct LS-TA in Triage Febrile Patients Into Major Categories of Infections: Viral, Bacterial or Active Tuberculosis.

Who this might be right for
Single Cell Sequencing TechnologyGene Expression ProfilingGene Expression+7 more
Chinese University of Hong Kong 200
Large-scale testing (Phase 3)UnknownNCT02722694
What this trial is testing

Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis (RA)
Jiangsu Simcere Pharmaceutical Co., Ltd. 360
Not applicableStudy completedNCT00000895
What this trial is testing

Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 85
Large-scale testing (Phase 3)Study completedNCT03021499
What this trial is testing

Aurinia Renal Response in Active Lupus With Voclosporin

Who this might be right for
Lupus Nephritis
Aurinia Pharmaceuticals Inc. 358
Large-scale testing (Phase 3)Study completedNCT00810277
What this trial is testing

Tocilizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic DMARDs

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 14
Large-scale testing (Phase 3)Study completedNCT02046603
What this trial is testing

Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 162
Testing effectiveness (Phase 2)Ended earlyNCT03001219
What this trial is testing

RO7123520 to Evaluate the Safety and Efficacy in Participants With Moderately To Severely Active Rheumatoid Arthritis (RA) Who Are Inadequately Responding to Anti-Tumor Necrosis Factor (TNF)-Alpha Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 109
Next Page